Skip to content

The Effect of Brachial Plexus Nerve Block on Distal Peripheral Nerve Conduction

The Effect of Brachial Plexus Nerve Block on Distal Peripheral Nerve Conduction

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01716078
Enrollment
0
Registered
2012-10-29
Start date
2011-11-30
Completion date
Unknown
Last updated
2016-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia

Keywords

Brachial Plexus, Nerve Block, Nerve Conduction

Brief summary

The purpose of this study is to determine the conducting ability of distal extremity nerves after a supraclavicular brachial plexus nerve block (with local anesthetic) has been placed at a more proximal location in the upper extremity.

Interventions

None listed

Sponsors

Defense and Veterans Center for Integrative Pain Management
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male and female military health care beneficiaries 18 years and older, capable of providing informed consent indicating awareness of the investigational nature of the study, in keeping with institutional policy * Written informed consent must be obtained from each patient prior to entering the study * Patients must be willing to have a regional anesthetic nerve block placed prior to their scheduled procedure * Patients must be willing to have neurodiagnostic tests performed prior to placement and after placement of the regional anesthesia nerve block

Exclusion criteria

* Refusal to have a brachial plexus nerve block placed * Refusal to have serial nerve conduction studies performed * Contraindication for a regional anesthesia nerve block (allergy to local anesthetic, infection at site of injection, elevated coagulation time) * Presence of conditions affecting the hand or arm (e.g., injury, infection) that might preclude the performance of nerve conduction studies * Presence of known major abnormalities of nerve conduction, e.g., absent median sensory potential in a patient scheduled for carpal tunnel release * Presence of conditions affecting the contralateral hand or arm (e.g., injury, infection) that might preclude the performance of sensory and motor studies to test block or absence of a contralateral upper extremity

Design outcomes

Primary

MeasureTime frameDescription
Compund Muscle Action Potential (CMAP) amplitude1 daymeasured for motor studies from baseline to peak in mV

Secondary

MeasureTime frameDescription
Distal Latency1 daythe interval between the stimulation of a compound muscle and the observed response. Normal nerve conduction velocity is above 40 m/sec in the lower extremities and above 50 m/sec in the upper extremities, but age, muscle disease, temperature, and other factors can influence the velocity.
Peak Latency1 day* This represents conduction along the majority of the axons * It is recorded at the peak of the waveform response
Onset Latency1 day* This represents conduction along the fastest axons * It is recorded at the initial deflection from baseline

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026